Clinical Trial

A Behavioral Digital Intervention For Parkinson's Disease

Study acronym: MOVE ON UP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this interventional, quasi-experimental study is to evaluate whether a digital dual-task exercise and behavioral program can improve physical activity and influence patient-reported outcomes in people with Parkinson's disease. The main questions it aims to answer are: 1. Is the MOVE ON UP digital intervention feasible and acceptable, based on recruitment, retention, adherence, and safety? 2. Does participation in the program lead to increased physical activity levels? 3. Does the intervention produce exploratory improvements in patient-reported outcomes such as motor symptoms, balance confidence, and quality of life? Because the study includes a comparison group, researchers will compare participants receiving the MOVE ON UP digital intervention with participants receiving usual care to determine whether the digital program produces measurable behavioral and functional changes. Participants will: 1. Complete baseline and post-intervention assessments of physical activity and patient-reported outcomes. 2. Engage in an 8-week digital dual-task exercise program, including: 2.1 Structured dual-task exercise sessions delivered digitally. 2.2 Educational content related to Parkinson's disease and physical activity. 2.3 Behavioral support elements informed by the COM-B model. 3. Use the digital platform to follow the program and complete follow-up questionnaires.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-10.
Trial Details
NCT Number NCT07705620
Lead Sponsor Egas Moniz - Cooperativa de Ensino Superior, CRL
Collaborators: Young Parkies Portugal, Aristotle University Of Thessaloniki, Università degli Studi "G. d'Annunzio" Chieti-Pescara, Omišalj-Njivice Gymnastics Club
Conditions Parkinson Disease, Exercise Training
Enrollment 68 participants
Start Date 2026-11-02
Primary Completion 2027-07-30 (estimated)
Study Completion 2027-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-16